Stock Market Reviews

DOCS (Doximity, Inc.) News

Get the latest news, insights, and market updates on DOCS (Doximity, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization
  HIMS deepens its AI and data strategy with personalized care tools, biomarker tracking, and smarter treatment matching.
  Jan 5, 2026 - $DOCS
• MongoDB, Doximity, DoubleVerify, and 8x8 Shares Skyrocket, What You Need To Know
  A number of stocks jumped in the afternoon session after investors wagered geopolitical tension would be contained following the U.S. military's operation in Venezuela, with the Dow hitting a fresh record.
  Jan 5, 2026 - $DOCS
• Should You Investigate Doximity, Inc. (NYSE:DOCS) At US$43.29?
  While Doximity, Inc. ( NYSE:DOCS ) might not have the largest market cap around , it received a lot of attention from a...
  Jan 3, 2026 - $DOCS
• 1 Profitable Stock with Impressive Fundamentals and 2 We Brush Off
  While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
  Dec 29, 2025 - $DOCS
• Tech, Media & Telecom Roundup: Market Talk
  Find insight on Doximity , Nvidia, CES and more in the latest Market Talks covering Technology, Media and Telecom.
  Dec 29, 2025 - $DOCS
• Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More
  Pre-Market Stock Futures: The futures are trading lower as we begin the final trading week of 2025, albeit a holiday-shortened one once again. The major indices all finished the session modestly lower on Friday, with the venerable S&P 500 taking early bows as it hit a fresh all-time high, joining the Dow Jones Industrial Average ... Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More
  Dec 29, 2025 - $DOCS
• How Tempus AI Is Advancing Toward Regulatory Pricing Catch-Up
  TEM sees modest Q3 reimbursement gains, but FDA and ADLT pathways for xT, xF and xR assays could narrow its pricing gap over 2025-2026.
  Dec 26, 2025 - $DOCS
• Doximity (DOCS) Stock Falls Amid Market Uptick: What Investors Need to Know
  In the latest trading session, Doximity (DOCS) closed at $43.53, marking a -3.22% move from the previous day.
  Dec 23, 2025 - $DOCS
• Why BofA Sees Strong Upside for Doximity (DOCS)
  Doximity (NYSE:DOCS) is one of the most promising mid-cap healthcare stocks under $50. On December 16, Bank of America analyst Allen Lutz reiterated his bullish stance on Doximity (NYSE:DOCS). He assigned a Buy rating to the stock with a $82 price target. This implies a highly attractive 88% upside potential for investors within the prevailing […]
  Dec 22, 2025 - $DOCS
• Doximity (DOCS) Stock Trades Up, Here Is Why
  Shares of medical professional network Doximity (NYSE:DOCS) jumped 3.3% in the afternoon session after the stock's positive momentum continued as a Bank of America analyst reiterated a Buy rating and an $82 price target on the stock.
  Dec 22, 2025 - $DOCS